Yanrong Liu

Prof. Dr. Yanrong Liu


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 November 2018 in Journal of Cellular and Molecular Medicine
Verified
Journal Article
Open access
PDF file
YLYanrong Liu
Yanrong Liu
JZJianmin Zhao
Jianmin Zhao
YZYali Zhao
Yali Zhao
SZShumin Zong
Shumin Zong
YTYixuan Tian
Yixuan Tian
CYCheng Yang
Cheng Yang
In this study, we investigated the therapeutic potential of lentinan in mouse models of inflammatory bowel disease (IBD) and colitis‐associated cancer (CAC). Lentinan decreased the disease activity index and macroscopic and microscopic colon tissue damage in dextran sulphate sodium (DSS)‐induced or TNBS‐induced models of colitis. High‐dose lentinan was more effective than salicylazosulfapyridine in the mouse models of colitis. Lentinan decreased the number of tumours, inflammatory cell infiltration, atypical hyperplasia and nuclear atypia in azoxymethane/DSS‐induced CAC model. It also decreased the expression of pro‐inflammatory cytokines, such as IL‐13 and CD30L, in IBD and CAC model mice possibly by inhibiting Toll‐like receptor 4 (TLR4)/NF‐κB signalling and the expression of colon cancer markers, such as carcinoembryonic antigen, cytokeratin 8, CK18 and p53, in CAC model mice. In addition, lentinan restored the intestinal bacterial microbiotal community structure in IBD model mice. Thus, it shows therapeutic potential in IBD and CAC model mice possibly by inhibiting TLR4/NF‐κB signalling‐mediated inflammatory responses and disruption of the intestinal microbiotal structure.

2 April 2021 in Signal Transduction and Targeted Therapy
Verified
Journal Article
Open access
PDF file
HZHeng Zhang
Heng Zhang
ZCZhi Chang
Zhi Chang
LQLu-Ning Qin
Lu-Ning Qin
BLBin Liang
Bin Liang
JHJing-Xia Han
Jing-Xia Han
Tao SunTao Sun
Tao Sun

2 July 2019 in Journal of Experimental & Clinical Cancer Research
Verified
Journal Article
Open access
PDF file
WZWeilong Zhong
Weilong Zhong
WYWendong Yang
Wendong Yang
YQYuan Qin
Yuan Qin
WGWenguang Gu
Wenguang Gu
YXYinyin Xue
Yinyin Xue
CYCheng Yang
Cheng Yang
Anti-angiogenic therapies demonstrate anti-tumor effects by decreasing blood supply to tumors and inhibiting tumor growth. However, anti-angiogenic therapy may leads to changes in tumor microenvironment and increased invasiveness of tumor cells, which in turn promotes distant metastasis and increased drug resistance. The CO-IP assays, N-STORM and cytoskeleton analysis were used to confirm the mechanism that p-VEGFR2/VE-cadherin/β-catenin/actin complex regulates vascular remodeling and improves the tumor microenvironment. 6-gingerol (6G), the major bioactive component in ginger, stabilized this complex by enhancing the binding of VEGFa to VEGFR2 with non-pathway dependent. Biacore, pull down and molecular docking were employed to confirm the interaction between 6G and VEGFR2 and enhancement of VEGFa binding to VEGFR2. Here, we report that microvascular structural entropy (MSE) may be a prognostic factor in several tumor types and have potential as a biomarker in the clinic. 6G regulates the structural organization of the microvascular bed to decrease MSE via the p-VEGFR2/VE-cadherin/β-catenin/actin complex and inhibit tumor progression. 6G promotes the normalization of tumor vessels, improves the tumor microenvironment and decreases MSE, facilitating the delivery of chemotherapeutic agents into the tumor core and thereby reducing tumor growth and metastasis. This study demonstrated the importance of vascular normalization in tumor therapy and elucidated the mechanism of action of ginger, a medicinal compound that has been used in China since ancient times.

5 September 2018 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
TXTing Xiao
Ting Xiao
WZWeilong Zhong
Weilong Zhong
JZJianmin Zhao
Jianmin Zhao
BQBaoxin Qian
Baoxin Qian
HLHuijuan Liu
Huijuan Liu
CYCheng Yang
Cheng Yang
Vasculogenic mimicry (VM) is a functional microcirculation pattern formed by aggressive tumor cells and is related to the metastasis and poor prognosis of many cancer types, including hepatocellular carcinoma (HCC). Thus far, no effective drugs have been developed to target VM. In this study, patients with liver cancer exhibited reduced VM in tumor tissues after treatment with Rhizoma Paridis. Polyphyllin I (PPI), which is the main component of Rhizoma Paridis, inhibited VM formation in HCC lines and transplanted hepatocellular carcinoma cells. Molecular mechanism analysis showed that PPI impaired VM formation by blocking the PI3k-Akt-Twist1-VE-cadherin pathway. PPI also displayed dual effects on Twist1 by inhibiting the transcriptional activation of the Twist1 promoter and interfering with the ability of Twist1 to bind to the promoter of VE-cadherin, resulting in VM blocking. This study is the first to report on the clinical application of the VM inhibitor. Results may contribute to the development of novel anti-VM drugs in clinical therapeutics.

1 January 2019 in Molecular Cancer Therapeutics
Verified
Journal Article
Open access
PDF file
HWHongzhi Wang
Hongzhi Wang
WZWeilong Zhong
Weilong Zhong
JZJianmin Zhao
Jianmin Zhao
HZHeng Zhang
Heng Zhang
QZQiang Zhang
Qiang Zhang
CYCheng Yang
Cheng Yang
Oleanolic acid exhibits extensive pharmacologic activities and takes significant antitumor effects. Its pharmacologic mechanism, however, still remained to be further clarified. In this study, we demonstrated that oleanolic acid attenuated the migration and invasion abilities, resulting in the suppression of the epithelial–mesenchymal transition (EMT) process in liver cancer cells, and inhibited the tumor growth of the peritoneal lymphocytes–bearing mice. We further proved that inducible nitric oxide synthase (iNOS) may be the potential target of oleanolic acid. We confirmed that oleanolic acid could promote the dimerization of iNOS, activating it, and subsequently increasing the production of nitric oxide. Further experiments indicated that oleanolic acid promoted the nitration of specific proteins and consequently suppressed their EMT-related biological functions. Furthermore, it has been confirmed that oleanolic acid enhanced the antitumor effects of regorafenib in liver cancer treatment. These results deepened our understanding of the pharmacologic mechanism of the antitumor effect oleanolic acid, and the importance of nitric oxide synthetase as a therapeutic target for liver cancer treatment.

1 November 2019 in Oncogene
Verified
Journal Article
Closed access
PDF file
BZBijiao Zhou
Bijiao Zhou
SZShumin Zong
Shumin Zong
WZWeilong Zhong
Weilong Zhong
YTYixuan Tian
Yixuan Tian
LWLumeng Wang
Lumeng Wang
YLYanrong Liu
Yanrong Liu